Human bite wounds have a notorious reputation, which is mostly based on one injury, the closed-fist injury. Human bites in other areas pose no greater risk than animal bites. Three general types of injuries can lead to complications: (1) closed-fist injury, (2) chomping injury to the finger, and (3) puncture-type wounds about the head caused by clashing with a tooth. Otherwise, the general principles of contaminated wound management apply to human bite wounds.
For more information, see Medscape's Wound Management Resource Center.
In a closed-fist injury, forces sufficient to break the skin from striking an opponent's tooth often inoculate the extensor tendon and its sheath. As the hand is flexed at the time of impact, the bacterial load is transferred caudally when the hand is opened and the tendon slides back to its relaxed state. Resulting contamination cannot be removed readily through normal cleansing and irrigation.
When a finger is bitten, such as in a chomping-type injury, tendons and their overlying sheaths are in close proximity to the skin. The wound may appear to be a minor abrasion-type injury, but careful inspection is required to rule out deep injury.
When a tooth strikes the head, even a deep puncture wound may appear innocuous. Deep, subgaleal, bacterial contamination is possible. This is especially true in young children who have relatively thin soft scalp and forehead tissue.
Exact incidence of human bite wounds is unknown, and many cases do not come to medical attention. Institutionalized patients with poor impulse control create a high-risk environment for human bite wounds. Lesch-Nyhan syndrome is an uncommon disorder that includes self-mutilation through biting.
In a 4-year retrospective review in the United Kingdom, 421 (13%) human bites were identified out of 3136 case notes. The majority of those bitten were young males, with 44% of the males aged 16-25 years. The male-to-female ratio was 3:1.[1]
The only drug therapy of significance in human bites is antibiotic treatment. Bacterial flora include that of the mouth and skin. Theoretically, penicillin treats oral pathogens and may suffice for prophylactic treatment as Staphylococcus species probably only infect bite wounds secondarily.
Once a human bite is infected, beta-lactamase–producing staphylococci must be addressed. Eikenella corrodens may not be covered by first-generation cephalosporins. Additionally, Eikenella species are resistant to clindamycin, penicillinase-resistant semisynthetic penicillins, and metronidazole. A broad-spectrum antibiotic, rather than combination therapy, is the usual choice for infected bite wounds. An in vitro study of 50 infected human bites by Talan et al indicated that amoxicillin-clavulanic acid and moxifloxacin demonstrated excellent activity against common isolates.[8]
Clinical Context: Drug combination that extends antibiotic spectrum of this penicillin to include bacteria normally resistant to beta-lactam antibiotics. DOC for noninfected human bite wounds. Dosing is based on amoxicillin component. Indicated for skin and skin structure infections caused by beta-lactamase-producing strains of Staphylococcus aureus.
Clinical Context: Drug combination that uses beta-lactamase inhibitor with ampicillin; covers skin, enteric flora, and anaerobes. DOC for infected bites.
Clinical Context: Alternative drug for infected bites; second-generation cephalosporin indicated for management of infections caused by susceptible gram-positive cocci and gram-negative rods. Many infections that are caused by gram-negative bacteria and are resistant to some cephalosporins and penicillins respond to cefoxitin.
Clinical Context: Inhibits the A subunits of DNA gyrase, resulting in inhibition of bacterial DNA replication and transcription.
Therapy must cover all likely pathogens in the context of the clinical setting.
Clinical Context: Used for passive immunization of any person with a wound that may be contaminated with tetanus spores.